- Home
- ETON vs NCMI Comparison
ETON vs NCMI Comparison
Compare ETON & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- NCMI
- Stock Information
- Founded
- ETON 2017
- NCMI 2005
- Country
- ETON United States
- NCMI United States
- Employees
- ETON N/A
- NCMI 254
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- NCMI Advertising
- Sector
- ETON Health Care
- NCMI Consumer Discretionary
- Exchange
- ETON Nasdaq
- NCMI Nasdaq
- Market Cap
- ETON 388.3M
- NCMI 444.2M
- IPO Year
- ETON 2018
- NCMI 2007
- Fundamental
- Price
- ETON $14.85
- NCMI $4.89
- Analyst Decision
- ETON Strong Buy
- NCMI Strong Buy
- Analyst Count
- ETON 3
- NCMI 5
- Target Price
- ETON $29.67
- NCMI $7.40
- AVG Volume (30 Days)
- ETON 636.4K
- NCMI 633.9K
- Earning Date
- ETON 08-07-2025
- NCMI 08-04-2025
- Dividend Yield
- ETON N/A
- NCMI 2.52%
- EPS Growth
- ETON N/A
- NCMI N/A
- EPS
- ETON N/A
- NCMI N/A
- Revenue
- ETON $48,327,000.00
- NCMI $238,300,000.00
- Revenue This Year
- ETON $103.21
- NCMI $8.56
- Revenue Next Year
- ETON $51.34
- NCMI $12.67
- P/E Ratio
- ETON N/A
- NCMI N/A
- Revenue Growth
- ETON 40.88
- NCMI 42.10
- 52 Week Low
- ETON $3.25
- NCMI $4.12
- 52 Week High
- ETON $21.48
- NCMI $7.60
- Technical
- Relative Strength Index (RSI)
- ETON 54.31
- NCMI 39.74
- Support Level
- ETON $13.78
- NCMI $4.57
- Resistance Level
- ETON $16.27
- NCMI $4.84
- Average True Range (ATR)
- ETON 0.83
- NCMI 0.16
- MACD
- ETON 0.32
- NCMI -0.02
- Stochastic Oscillator
- ETON 77.67
- NCMI 24.36
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NCMI National CineMedia Inc.
National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.